Nis Register Study Comparing Seroquel and Seroquel Prolong

AstraZeneca200 enrolled

Overview

The general aim of this non interventional study is to clarify what are the current clinical treatment practices of Quetiapine Immediate Release and Quetiapine Extended Release. The primary objectives of the study are:1.To collect information on the used Quetiapine Immediate Release or Quetiapine Extended Release medication 2.To collect information on duration and number of hospitalisation days 3.Change of GAF points

Study Type

OBSERVATIONAL

Enrollment

200

Conditions

Comparing Hospitalisation Time With Seroquel and Seroquel Prolong

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: * Medication: Seroquel or Seroquel Prolong * Diagnosis: F20-F29 or F30-F31 (ICD-10) * In-patient Exclusion Criteria: * None

Locations (1)

Research Site

Lappeenranta, Finland

Outcomes

Primary Outcomes

Hospitalisation time

Time frame: 2008-2010

Treatment practice

Time frame: 2008-2010

Secondary Outcomes

Primary diagnosis

Time frame: 2008-2010

Medication at the end of hospitalisation

Time frame: 2008-2010

GAF rating points

Time frame: 2008-2010

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.